Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02974543 · ClinicalTrials.gov registry record · NA
Auditory-somatosensory Stimulation to Alleviate Tinnitus
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02974543: Completed NA study, sponsored by University of Michigan.
NCT02974543 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02974543, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test a subject operated device to lessen tinnitus (ringing in the ear), based on subject-feedback for stimulus presentation.
Primary Outcome
Change in TFI score (mean of weekly assessments for 4 weeks) from baseline for treatment and sham groups. TFI is a clinical questionnaire that assesses tinnitus impact on a subject's quality of life. It uses a scale of 0 - 100 where 0 means no negative impact on quality of life from tinnitus and 100 is devastating impact It will be administered weekly through out the study.
Interventions
- DEVICE Sham Treatment: unimodal auditory stimulation
- DEVICE Active Treatment: Bimodal auditory-somatosensory stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02974543 record still lists
NCT02974543 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Treatment: unimodal auditory stimulation is the first listed.
NCT02974543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02974543 about?
NCT02974543 is a clinical study titled "Auditory-somatosensory Stimulation to Alleviate Tinnitus". The purpose of this study is to develop and test a subject operated device to lessen tinnitus (ringing in the ear), based on subject-feedback for stimulus presentation.
What is the current status of trial NCT02974543?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2014-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02974543?
The interventions under investigation include: Sham Treatment: unimodal auditory stimulation (DEVICE), Active Treatment: Bimodal auditory-somatosensory stimulation (DEVICE).
Who is sponsoring clinical trial NCT02974543?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02974543's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia